New era for ME/CFS research as top cytokine study attracts media headlines
The immune systems of patients who have recently developed ME/CFS look markedly different from those who have been ill for much longer, according to a major new study from Drs. Ian Lipkin and Mady Hornig at Columbia University. This shift in immune function hadn’t been seen before.
Discuss the article on the Forums.

Immune and Pathogen Resources

Discussion in 'Antivirals, Antibiotics and Immune Modulators' started by Cort, Nov 13, 2009.

  1. Cort

    Cort Phoenix Rising Founder

    Messages:
    7,036
    Likes:
    480
    Raleigh, NC
  2. Just noticed that the Ampligen article needs a little bit of updating:
    " Hemispherx replied and after both the drug and the company went under further reviews the FDA passed the drug onto the final review; we’ll probably know by spring 2009 whether Ampligen will become the first FDA-approved drug for chronic fatigue syndrome (ME/CFS)."
    http://www.aboutmecfs.org/Trt/TrtAmp.aspx

    Feel free to delete this after the article is updated.

    Thanks Cort!

    Rachel xx
     
  3. JT1024

    JT1024 Senior Member

    Messages:
    560
    Likes:
    369
    Massachusetts

See more popular forum discussions.

Share This Page